Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biodesix Inc (NQ: BDSX )

1.400 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.400
Bid (Size) 1.300 (1)
Ask (Size) 2.100 (2)
Prev. Close 1.400
Today's Range 1.400 - 1.400
52wk Range 0.9550 - 3.000
Shares Outstanding 78,457,943
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference
From Biodesix, Inc.
Via Business Wire

Performance

YTD
-31.71%
-31.71%
1 Month
-15.66%
-15.66%
3 Month
-30.00%
-30.00%
6 Month
-30.00%
-30.00%
1 Year
-5.41%
-5.41%

More News

Read More
Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing
From Biodesix, Inc.
Via Business Wire
Recap: Biodesix Q1 Earnings
Via Benzinga
Biodesix Earnings Perspective: Return On Capital Employed
Via Benzinga
Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors
From Biodesix, Inc.
Via Business Wire
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference
From Biodesix, Inc.
Via Business Wire
Biodesix Announces First Quarter 2023 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference
From Biodesix, Inc.
Via Business Wire
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
From Biodesix, Inc.
Via Business Wire
Over $12 Million Bet On TD Holdings? Check Out These 3 Penny Stocks Insiders Are Buying
Via Benzinga
Looking Into Biodesix's Recent Short Interest
Via Benzinga
$12.5 Million Bet On Biodesix? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Biodesix Announces First Four Private Payer Coverage Policies for the Nodify XL2® Test
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Appointment of Lawrence (Lair) T. Kennedy, Jr. to Board of Directors
From Biodesix, Inc.
Via Business Wire
Biodesix Ranked Top Proteomics Solutions Company by Life Sciences Review Magazine
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
How Is The Market Feeling About Biodesix?
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Okta Shares Are Trading Higher By Around 14%; Here Are 27 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.